Becker's Healthcare November 27, 2024
Alexandra Murphy

Sanofi is preparing a new vaccine and biopharmaceutical manufacturing facility in Singapore, located at Tuas Biomedical Park, Bloomberg reported Nov. 27.

The plant, dubbed Modulus, represents an investment of approximately $600 million and is set to be fully operational by mid-2026.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
New 'how-to guide' for future rapid vaccine development
Medicare prescription drug pricing variance: 5 things to know
Payer group 'deeply concerned' by Medicare weight loss drug coverage proposal
What are the insurance commissioners talking about? 5 healthcare notes
Biden administration pushes anti-obesity drug pressure to Trump

Share This Article